Breaking through the complexity of managing type 2 diabetes – Case study 3
How to treat a patient with SGLT-2 and GLP-1 failure and the need to intensify with selection of the option of iGlarLixi
Learning objectives:
- An approach to treatment intensification in the patient with T2DM and a suboptimal response to multiple oral and injectable glycaemic-lowering therapies
- The importance of setting appropriate treatment targets and of routine screening for diabetes-related comorbidities
- An understanding of the synergistic mechanisms of action of shorter-acting GLP-1 RAs and basal insulin when used in combination
- The rationale behind fixed-ratio combinations, such as iGlarLixi, and the appropriate administration of these agents
To access this module, please register or login: